eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) announced that its Board has approved a 1-for-25 reverse stock split of the Company’s common stock, effective at 12:01 A.M. ET, on January 12.

eFFECTOR Therapeutics，Inc.（纳斯达克股票代码：EFTR）宣布，其董事会已批准该公司普通股的25股1股反向股票分割，于美国东部时间1月12日上午12:01生效。

Source: Press Release

来源：新闻稿

More on eFFECTOR Therapeutics eFFECTOR updates Phase 1/2 data for breast cancer therapy eFFECTOR stock rises after FDA fast track status for breast cancer therapy Seeking Alpha’s Quant Rating on eFFECTOR Therapeutics Historical earnings data for eFFECTOR Therapeutics Financial information for eFFECTOR Therapeutics .

更多关于效应器治疗的信息效应器更新乳腺癌治疗的1/2期数据在FDA乳腺癌治疗快速通道状态后，效应器股票上涨，寻求Alpha对效应器治疗的定量评级效应器治疗的历史收益数据效应器治疗的财务信息。